Biota Holdings has announced the acquisition of the key assets and programs of Prolysis, an antibacterial drug discovery company located in Oxford, England. Prolysis has two primary projects that are ....
Biota Holdings has announced the acquisition of the assets and drug development programs of MaxThera, an antibacterial drug discovery company located in Boston, US. The acquisition is subject to the satisfaction ....
PPD has signed an agreement to acquire BioDuro, a drug discovery outsourcing company that provides integrated services to biopharmaceutical companies. The acquisition will expand the former's drug development ....
Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma have entered into a development and commercialization agreement for LPLchip, a diagnostic tool to rapidly diagnose patients with complete ....
Cevec Pharmaceuticals and the contract manufacturer InVivo BioTech Services have announced the signing of a strategic license agreement. This license enables the latter to offer its customers the production ....
Symyx Technologies has announced an out-of-the-box integration of Symyx Notebook and Thermo Scientific Watson Laboratory Information System (LIMS). The integration enables scientists who are engaged in ....
Kinaxo Biotechnologies has entered into a collaboration with Roche Diagnostics in Penzberg, Germany. Under the agreement, the former's phosphoproteomics technology PhosphoScout will be applied to support ....
GE Healthcare announced a strategic collaboration with GoIndustry DoveBid (GoIDB). The partnership enhances the former's asset disposal capabilities and expands its ability to provide critical business ....
Qiagen has acquired DxS, a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, UK. The transaction is valued at approximately US$95 million in cash, ....
Cancer Therapeutics CRC (CTx), Australia, has announced a collaboration with Duke University, North Carolina, US to discover and develop drugs for the treatment of cancer, based on research that is undertaken ....